AJP - GI Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 294: G899-G905, 2008. First published January 31, 2008; doi:10.1152/ajpgi.00411.2007
0193-1857/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/4/G899    most recent
00411.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chow, J. Y. C.
Right arrow Articles by Carethers, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chow, J. Y. C.
Right arrow Articles by Carethers, J. M.

HORMONES AND SIGNALING

TGF-β mediates PTEN suppression and cell motility through calcium-dependent PKC-{alpha} activation in pancreatic cancer cells

Jimmy Y. C. Chow,1 Hui Dong,1 Khai T. Quach,1 Phuoc Nam Van Nguyen,1 Kevin Chen,1 and John M. Carethers1,2,3

1Division of Gastroenterology Department of Medicine and 2Rebecca and John Moores Comprehensive Cancer Center University of California San Diego, and 3Veterans Affairs San Diego Healthcare System, San Diego, California

Submitted 12 September 2007 ; accepted in final form 30 January 2008

Transforming growth factor-β (TGF-β) suppresses growth via the TGF-β-SMAD pathway but promotes growth in cancer cells with disrupted SMAD signaling and corresponds to an invasive phenotype. TGF-β also downregulates the tumor suppressor PTEN that is rarely mutated in sporadic pancreatic cancer; this downregulation may mediate cell proliferation and invasiveness, but the mechanism is unknown. Here, we examined whether TGF-β modulation of PTEN was mediated by protein kinase C (PKC). We have previously demonstrated that SMAD4-null BxPc-3 pancreatic cancer cells treated with TGF-β1 (10 ng/ml) suppressed PTEN expression and increased cell proliferation. TGF-β-treated cells were examined for PKC activation and its coupling to PTEN expression, utilizing pharmacological and knockdown methods. Calcium mobilization and cell migration were also examined. In BxPc-3 cells, only two PKC isoforms were activated by TGF-β, and PTEN downregulation by TGF-β was specifically mediated by PKC-{alpha}. In parallel, TGF-β rapidly induced an increase in cytoplasmic free calcium from intracellular stores, consistent with subsequent PKC-{alpha} activation. The TGF-β-induced increase in cell migration was blocked by knockdown of PKC-{alpha}. Thus calcium-dependent PKC-{alpha} mediates TGF-β-induced transcriptional downregulation of PTEN, and this pathway promotes cell migration in a SMAD4-null environment. The TGF-β-PKC-{alpha}-PTEN cascade may be a key pathway for pancreatic cancer cells to proliferate and metastasize.

transforming growth factor-β; PTEN; protein kinase C



Addressfor reprint requests and other correspondence: J. M. Carethers, Div. of Gastroenterology, UCSD, Univ. Center 303, MC0063, 9500 Gilman Dr., La Jolla, CA 92093-0063 (e-mail: jcarethers{at}ucsd.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Y. C. Chow, M. Ban, H. L. Wu, F. Nguyen, M. Huang, H. Chung, H. Dong, and J. M. Carethers
TGF-{beta} downregulates PTEN via activation of NF-{kappa}B in pancreatic cancer cells
Am J Physiol Gastrointest Liver Physiol, February 1, 2010; 298(2): G275 - G282.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Tiedemann, O. Hussein, G. Sadvakassova, Y. Guo, P. M. Siegel, and S. V. Komarova
Breast Cancer-derived Factors Stimulate Osteoclastogenesis through the Ca2+/Protein Kinase C and Transforming Growth Factor-{beta}/MAPK Signaling Pathways
J. Biol. Chem., November 27, 2009; 284(48): 33662 - 33670.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. Sun, R. D. Ramnath, R. Tamizhselvi, and M. Bhatia
Role of protein kinase C and phosphoinositide 3-kinase-Akt in substance P-induced proinflammatory pathways in mouse macrophages
FASEB J, April 1, 2009; 23(4): 997 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. T. Ihle, R. Lemos Jr., P. Wipf, A. Yacoub, C. Mitchell, D. Siwak, G. B. Mills, P. Dent, D. L. Kirkpatrick, and G. Powis
Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance
Cancer Res., January 1, 2009; 69(1): 143 - 150.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.